Hashmi, Shahrukh K.
Powles, Ray C.
Ma, David
Muhsen, Ibrahim N. https://orcid.org/0000-0002-7156-2532
Aljurf, Mahmoud
Niederwieser, Dietger
Weisdorf, Daniel J.
Koh, Mickey B. C.
Greinix, Hildegard
Article History
Received: 9 October 2022
Accepted: 18 December 2022
First Online: 6 June 2023
Declarations
:
: N/A.
: MK: Honoraria and Advisory board from Gilead. DW: Research Funding from FATE therapeutics and Incyte. SKH: Honoraria from Pfizer, Novartis, Janssen, Therakos Mallinckrodt, Sanofi, Roche. All other authors declare no competing interests.